BioSpace News Archive

Genetown

The iLet® Bionic Pancreas Significantly Reduced HbA1c and Improved Time in Range vs Standard of Care for a Diverse Range of People with Type 1 Diabetes

Beta Bionics, Inc. — The results of the multi-center randomized Insulin-Only Bionic Pancreas Pivotal Trial were presented by Dr. Steven J. Russell, Associate Professor of Medicine, Harvard Medical School, at the International Conference on Advanced Technologies & Treatments for Diabetes.

April 30, 2022
·
7 min read
Policy

Inmagene Receives FDA’s IND Clearance for OX40 Antagonist

Inmagene Biopharmaceuticals announces that the U.S. Food and Drug Administration has cleared drug candidate IMG-007, a monoclonal antibody against OX40, to proceed to Phase I clinical development.

April 30, 2022
·
5 min read
Business

Yiling Pharmaceutical Reports Revenue of $1.53B in 2021

Yiling Pharmaceutical released its 2021 Annual Report Friday and disclosed the main development statistics.

April 30, 2022
·
1 min read
Drug Development

Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT

Milestone Pharmaceuticals Inc. announced data from NODE-302, its Phase 3 open-label extension study of etripamil nasal spray, the Company’s novel, investigational, calcium channel blocker in patients with paroxysmal supraventricular tachycardia.

April 30, 2022
·
7 min read